Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc. (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics. The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Grant Levine.
[starbox id=1]
